Telesis Bio, Inc.

NASDAQ:TBIO

1.11 (USD) • At close November 7, 2024
Bedrijfsnaam Telesis Bio, Inc.
Symbool TBIO
Munteenheid USD
Prijs 1.11
Beurswaarde 1,967,975
Dividendpercentage 0%
52-weken bereik 1.11 - 15.462
Industrie Medical Devices
Sector Healthcare
CEO Dr. Todd R. Nelson MBA, Ph.D.
Website https://codexdna.com

An error occurred while fetching data.

Over Telesis Bio, Inc.

Codex DNA, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. Its solutions include BioXp system that empowers researchers to go from a digital DNA sequence to endpoint-ready synthetic DNA; BioXp portal, an online

Vergelijkbare Aandelen

STAAR Surgical Company logo

STAAR Surgical Company

STAA

31.46 USD

LifeStance Health Group, Inc. logo

LifeStance Health Group, Inc.

LFST

7.68 USD

Neogen Corporation logo

Neogen Corporation

NEOG

15.78 USD

Pacira BioSciences, Inc. logo

Pacira BioSciences, Inc.

PCRX

17.7 USD

Denali Therapeutics Inc. logo

Denali Therapeutics Inc.

DNLI

29.6 USD

Progyny, Inc. logo

Progyny, Inc.

PGNY

16.53 USD

Roivant Sciences Ltd. logo

Roivant Sciences Ltd.

ROIV

11.76 USD

Certara, Inc. logo

Certara, Inc.

CERT

10.99 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)